🇺🇸 FDA
Pipeline program

Intravenous dexmedetomidine

XJH-A-2017-10-10

Unknown small_molecule completed

Quick answer

Intravenous dexmedetomidine for Aneurysm Cerebral is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Aneurysm Cerebral
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials